ATE529135T1 - Röntgenkontrastformulierung mit einem gemisch aus einem jodierten monomer und dimer - Google Patents

Röntgenkontrastformulierung mit einem gemisch aus einem jodierten monomer und dimer

Info

Publication number
ATE529135T1
ATE529135T1 AT05731581T AT05731581T ATE529135T1 AT E529135 T1 ATE529135 T1 AT E529135T1 AT 05731581 T AT05731581 T AT 05731581T AT 05731581 T AT05731581 T AT 05731581T AT E529135 T1 ATE529135 T1 AT E529135T1
Authority
AT
Austria
Prior art keywords
mixture
dimer
ray contrast
triiodo
monomer
Prior art date
Application number
AT05731581T
Other languages
German (de)
English (en)
Inventor
Muthunadar Periasamy
Brian Doty
Original Assignee
Mallinckrodt Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Llc filed Critical Mallinckrodt Llc
Application granted granted Critical
Publication of ATE529135T1 publication Critical patent/ATE529135T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05731581T 2004-03-11 2005-03-11 Röntgenkontrastformulierung mit einem gemisch aus einem jodierten monomer und dimer ATE529135T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55224004P 2004-03-11 2004-03-11
PCT/US2005/008389 WO2005087272A2 (en) 2004-03-11 2005-03-11 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer

Publications (1)

Publication Number Publication Date
ATE529135T1 true ATE529135T1 (de) 2011-11-15

Family

ID=34964357

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05731581T ATE529135T1 (de) 2004-03-11 2005-03-11 Röntgenkontrastformulierung mit einem gemisch aus einem jodierten monomer und dimer

Country Status (12)

Country Link
US (1) US8679460B2 (https=)
EP (2) EP1725268B1 (https=)
JP (1) JP2007528424A (https=)
KR (1) KR20070015517A (https=)
CN (1) CN1938050A (https=)
AT (1) ATE529135T1 (https=)
AU (1) AU2005221716A1 (https=)
CA (1) CA2559628A1 (https=)
ES (1) ES2374633T3 (https=)
IL (1) IL177888A0 (https=)
NO (1) NO20064629L (https=)
WO (1) WO2005087272A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8445725B2 (en) * 2008-01-14 2013-05-21 Mallinckrodt Llc Process for the preparation of iosimenol
US11219696B2 (en) 2008-12-19 2022-01-11 Nationwide Children's Hospital Delivery of polynucleotides using recombinant AAV9
CN102271715A (zh) 2009-01-09 2011-12-07 通用电气医疗集团股份有限公司 对比剂组合物
KR101915821B1 (ko) * 2010-03-23 2018-11-06 지이 헬스케어 에이에스 안정화된 ｘ―선 진단용 조성물의 제조
US20130039888A1 (en) 2011-06-08 2013-02-14 Nationwide Children's Hospital Inc. Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders
JP2013091701A (ja) 2011-10-25 2013-05-16 Dow Corning Toray Co Ltd 硬化性組成物
WO2013086207A1 (en) * 2011-12-06 2013-06-13 The Ohio State University Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease
CN107982550A (zh) 2012-01-11 2018-05-04 通用电气医疗集团股份有限公司 具有低碘浓度的x-射线成像造影介质和x-射线成像方法
EP2854531A4 (en) * 2012-05-30 2016-03-23 Verrow Pharmaceuticals Inc STABILIZED FORMULATIONS WITH IODIC CONTRASTIVE AND CYCLODEXTRINS
AU2013296425B2 (en) * 2012-08-01 2018-06-07 Nationwide Children's Hospital Intrathecal delivery of recombinant adeno-associated virus 9
KR102151088B1 (ko) * 2018-07-10 2020-09-02 한국원자력연구원 소체와 연결된 실 모양의 구조물 가시화 조성물 및 이의 가시화 방법
CN112386712B (zh) * 2020-11-09 2022-08-30 张洪 分子探针及其制备方法和用途
CN119656340A (zh) * 2024-12-13 2025-03-21 福安药业集团宁波天衡制药有限公司 一种碘佛醇注射液及其制备方法
CN120899953B (zh) * 2025-10-13 2025-12-12 浙江迪安鉴识科技有限公司 一种尸体用血管造影剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511871A1 (fr) * 1981-08-28 1983-03-04 Guerbet Sa Procede pour augmenter la tolerance des produits opacifiants et produits opacifiants ainsi obtenus
US5698739A (en) 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
WO1993010825A1 (en) * 1991-12-03 1993-06-10 Mallinckrodt Medical, Inc. Nonionic x-ray contrast agents, compositions and methods
IT1256248B (it) * 1992-12-24 1995-11-29 Bracco Spa Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
DE19627309C2 (de) 1996-06-27 1999-07-29 Schering Ag Wäßrige injizierbare Formulierungen verwendbar als Kontrastmittel
ITMI20011706A1 (it) 2001-08-03 2003-02-03 Bracco Imaging Spa Agenti di contrasto radiografici ionici e non ionici, utilizzabili per l'indagine diagnostica combinata tramite raggi-x e risonanza magnetic
US8518373B2 (en) * 2001-08-03 2013-08-27 Bracco Imaging Spa Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics
US7250153B2 (en) * 2002-12-12 2007-07-31 Biophysica Research, Inc. Contrast media formulations having improved biological tolerance

Also Published As

Publication number Publication date
WO2005087272A3 (en) 2006-06-22
JP2007528424A (ja) 2007-10-11
WO2005087272A2 (en) 2005-09-22
US20080317675A1 (en) 2008-12-25
ES2374633T3 (es) 2012-02-20
IL177888A0 (en) 2006-12-31
EP1725268B1 (en) 2011-10-19
EP2253332B1 (en) 2012-10-10
EP2253332A2 (en) 2010-11-24
US8679460B2 (en) 2014-03-25
AU2005221716A1 (en) 2005-09-22
EP1725268A2 (en) 2006-11-29
KR20070015517A (ko) 2007-02-05
NO20064629L (no) 2006-11-28
EP2253332A3 (en) 2011-03-23
CN1938050A (zh) 2007-03-28
CA2559628A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
ATE529135T1 (de) Röntgenkontrastformulierung mit einem gemisch aus einem jodierten monomer und dimer
CR11155A (es) Formulaciones solidas de artropodicidas de carboxamida
BRPI0519088A2 (pt) formulaÇÕes de tacrolimo nanoparticuladas
CL2004000918A1 (es) Compuestos derivados de quinuclidina, antagonistas del receptor muscarinico m3; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para tratar una condicion anti-inflamatoria o alergica, en particular de las vias respiratoria
GT200600164A (es) Derivados de dihidrobenzofuranos y usos de los mismos
WO2009008734A3 (en) Contrast agents
CO6280399A2 (es) Peptidil nitrilos y uso de los mismos como inhibidores de peptidil peptidasa i
JP2010175878A5 (https=)
MX2008000141A (es) Moduladores de lxr basados en imidazol.
ATE538171T1 (de) Kohlenstoffnanoröhrchen enthaltende kautschukzusammensetzungen
JP2013505946A5 (https=)
ATE491433T1 (de) Pflegemittel mit freisetzungspartikel
ATE496881T1 (de) Kontrastmittel
DE675738T1 (de) Wässerige Einspritzbare Zusammensetzungen verwendbar zur Radiodiagnose enthaltendenJodierten Aromatischen Verbindungen zur VerwendungalsRöntgenkontrastmittel.
JP2009526123A5 (https=)
WO2007084595A3 (en) Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
MX2007012936A (es) Derivados de dihidrobenzofurano y usos de los mismos.
CL2008001775A1 (es) Compuestos derivados de 2-amino-7-alquinil-[1,8]naftiridona, inhibidores de vegfr-3; composición farmacéutica; combinación farmacéutica; procedimiento de preparación; compuesto intermediario; y uso en el tratamiento del cáncer.
FR2872817B1 (fr) Composition de caoutchouc pour pneumatique a base d'un hydroxyde metallique renforcant
ATE556074T1 (de) Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
ES2184523T3 (es) Procedimientos para obtener una composicion detergente granular que tiene un aspecto y solubilidad mejoradas.
EP2098522A4 (en) NEW CONNECTION WITH AFFINITY TO AMYLOID
DE502005006701D1 (de) Triterpenhaltiger oleogelbildner, triterpenhaltiges oleogel und verfahren zur herstellung eines triterpenhaltigen oleogels
HRP20140215T1 (hr) Kombinacija koja sadrži paklitaksel za lijeäśenje raka jajnika
DE602006015062D1 (de) 3-aminocarbazolverbindungen, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties